Publication | Closed Access
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study
27
Citations
35
References
2017
Year
We did not find a higher AMI risk in saxagliptin users compared with users of other selected antihyperglycemic agents during the first 5 years after U.S. Food and Drug Administration approval of the drug.
| Year | Citations | |
|---|---|---|
Page 1
Page 1